https://www.moneycontrol.com/news/business/markets/biocon-slumps-4-after-us-fda-red-flags-malaysia-unit-11552111.html
0
0
39 words
0
Comments
The official action indicated or an "OAI" classification of the insulin unit by the FDA can delay or withhold approvals for products manufactured at the facility
You are the first to view
Create an account or login to join the discussion